Two Sigma Advisers’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,200
Closed -$57.7K 2533
2025
Q1
$57.7K Buy
12,200
+1,400
+13% +$8.15K ﹤0.01% 2309
2024
Q4
$74.7K Sell
10,800
-74,800
-87% -$548K ﹤0.01% 2253
2024
Q3
$496K Sell
85,600
-80,500
-48% -$489K ﹤0.01% 1706
2024
Q2
$885K Buy
166,100
+85,400
+106% +$392K ﹤0.01% 1609
2024
Q1
$307K Sell
80,700
-7,800
-9% -$28.3K ﹤0.01% 2067
2023
Q4
$209K Sell
88,500
-16,000
-15% -$37.5K ﹤0.01% 2216
2023
Q3
$289K Buy
104,500
+33,800
+48% +$103K ﹤0.01% 1992
2023
Q2
$223K Buy
70,700
+35,100
+99% +$127K ﹤0.01% 2066
2023
Q1
$185K Buy
35,600
+3,300
+10% +$23.7K ﹤0.01% 2282
2022
Q4
$240K Buy
32,300
+2,100
+7% +$18.9K ﹤0.01% 2135
2022
Q3
$378K Buy
30,200
+5,100
+20% +$60.9K ﹤0.01% 1962
2022
Q2
$193K Sell
25,100
-26,000
-51% -$218K ﹤0.01% 2285
2022
Q1
$517K Buy
51,100
+17,300
+51% +$158K ﹤0.01% 1973
2021
Q4
$244K Buy
+33,800
New +$185K ﹤0.01% 2214

Other funds holding SRTS

Two Sigma Advisers's SRTS Position: Q2 2025 in Review

Two Sigma Advisers sold out of Sensus Healthcare (SRTS) in Q2 2025, closing a stake of 12,200 shares — an estimated $57.7K sold.

Two Sigma Advisers first reported a position in SRTS in Q4 2021 and held it in 14 quarters. The position peaked at $885K in Q2 2024. 46 funds tracked by Wall St. Rank hold SRTS as of Q2 2025.

  • Two Sigma Advisers reported no remaining Sensus Healthcare position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 12,200 Sensus Healthcare shares in Q2 2025, an estimated $57.7K.
  • Two Sigma Advisers first reported a position in Sensus Healthcare in Q4 2021 and held it in 14 quarters.
  • Two Sigma Advisers's Sensus Healthcare position peaked at $885K in Q2 2024.
  • 46 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.